Adam Gregerman, Ph.D., is an associate professor of Jewish Studies in the Department of Theology and Religious Studies and Associate Director of the Institute for Jewish-Catholic Relations at Saint Joseph’s University. His research focuses on the complex relationship between Jews and Christians from antiquity to the present. He published Building on the Ruins of the Temple: Apologetics and Polemics in Early Christianity and Rabbinic Judaism (Mohr Siebeck, 2016). His articles on biblical interpretation, mission and conversion, rabbinic theology, religious polemics, and theologies of the land of Israel have appeared in journals such as Theological Studies, Modern Theology, Interpretation, Cross Currents, Journal of Ecumenical Studies, and Studies in Christian-Jewish Relations. Dr. Gregerman has presented lectures in diverse settings, including academic conferences, synagogues, churches, and community centers, and taught in seminaries and universities. He is a member of the Committee on Ethics, Religion, and the Holocaust at the U.S. Holocaust Memorial Museum, Vice-Chair of the Council of Centers on Jewish-Christian Relations, and Academic Advisor to the National Council of Synagogues.
Aimee LaPointe Terosky, Ed.D., is an associate professor of educational leadership at Saint Joseph's University and the Director of the IDEPEL Doctoral Program. Dr. Terosky teaches courses in K-12 and Higher Education leadership at the doctoral and masters levels. Prior to her arriving at Saint Joseph's in January 2011, Dr. Terosky was an adjunct assistant professor of higher and postsecondary education at Teachers College, Columbia University, where she taught courses on teaching and learning and faculty development in postsecondary education settings. From 2006-2011, she also served as the assistant principal of Public School #334, The Anderson School in New York City, which received the 2007 New York City Blackboard Award for Outstanding Public Middle School. Areas of expertise: urban principals, faculty careers, women faculty advancement, K-12 and higher education teaching and learning
Doctor and neuroscientistThe Neuro - Montreal Neurological Institute and Hospital
Appetite, Obesity, Parkinson's Disease, Brain Imaging, music and the mind
Dr. Alain Dagher is a neurologist specializing in movement disorders and functional brain imaging. His research aims at understanding the function of the basal ganglia, with a particular emphasis on appetitive behaviours. This involves studying how we learn about rewards and punishments, and become motivated to engage in reward-seeking behaviour. The two main techniques used are positron emission tomography (PET) targeting the dopamine system, and functional magnetic resonance imaging (fMRI). The research focusses on Parkinson's Disease, stress, drug addiction (notably cigarette smoking), pathological gambling, and obesity. Dr. Dagher is funded by CIHR, FRSQ, NIDA, the Parkinson Society of Canada, the Institute for Research on Pathological Gambling and Related Disorders, and Unilever PLC.
Dr. Aldona Spiegel certified in plastic surgery by the American Board of Plastic Surgery. She completed her medical training at the University of Ottawa Faculty of Medicine. Spiegel completed a residency in general surgery and plastic surgery at John Hopkins Hospital. She also completed a residency in plastic surgery and a fellowship in microsurgery at Baylor College of Medicine. Spiegel's clinical focus is microsurgery, breast reconstruction, breast sensation and specialized perforator flaps (DIEP, SIEA, SGAP flaps). Her clinical expertise allows her to focus on research in innovative surgical techniques, such as muscle-preserving flaps.
Dr. Tabrizchi is a clinical interventional cardiologist at the LifeBridge Health Cardiovascular Institute in Maryland. He completed his fellowship at Winthrop-University Hospital. He did his residency at Washington Hospital Center, Children’s National Medical Center and National Institutes of Health (NIH). He completed medical school at Nova Southeastern University of College of Osteopathic Medicine. Dr. Tabrizchi is published in national and international medical journals.
Dr. Amit Shahane, PhD, is a clinical psychologist who serves as the director of the Behavioral Medicine Center at the University of Virginia Health System. Dr. Shahane specializes in treating psychological disorders, including PTSD, that impact medical illness. His research interests include examining the effectiveness of cognitive and behavioral treatments for insomnia, as well as healthcare utilization research, such as the effect of HIV stigma. UVA's Behavioral Medicine Center diagnoses, treats and prevents medical problems either caused or aggravated by lifestyle or stress, including: • Depression and anxiety • Migraine and tension headaches • Nervous stomach and irritable bowel syndrome • Sleep problems • Eating disorders Listen to Shahane discuss sleep problems: http://wina.com/morning-news/dr-amit-shahane-live-well/ Shahane discusses PTSD: http://www.newsplex.com/content/news/Fourth-of-July-fireworks-potential-PTSD-trigger-for-area-veterans-385267411.html
Amr M. Moursi, DDS, PhD, is a professor and chair of the Department of Pediatric Dentistry at NYU College of Dentistry. His research focuses on early childhood oral health, including the use of silver diamine fluoride (SDF) to fight cavities, birth defects of the head and skull, nutrition and oral health, and developing the pediatric dentistry workforce. Dr. Moursi is the author or co-author of more than 100 published articles, book chapters, and policy briefs, and is the editor of the textbook "Clinical Cases in Pediatric Dentistry" (Wiley-Blackwell). He is also a contributor for the 2020 U.S. Surgeon General’s Report on Oral Health. Dr. Moursi is a board-certified diplomate of the American Board of Pediatric Dentistry. He serves on the Executive Committee and as a National Spokesperson for the American Academy of Pediatric Dentistry (AAPD). He has extensive experience with print and broadcast media and is host of "The Dental Health Show" on Doctor Radio, SiriusXM satellite radio. Watch Dr. Moursi on ABC 7 discussing how to keep baby teeth healthy: https://youtu.be/ybKe5G1kodw
Dr. Badura Brack teaches Abnormal, Health, and Introductory Psychology, and she supervises the psychology internship program at Creighton University. Dr. Badura Brack is developing and testing a version of Attention Training Treatment that appears efficacious in treating combat-related Posttraumatic Stress Disorder (PTSD), as well as using magnetoencephalography (MEG) to identify regions where the brain functions abnormally in PTSD and determine if more normal neural functioning can be restored after attention training treatment.
McMichael has published numerous articles and book chapters on the subjects of scalp and hair disorders and quality of life issues surrounding disorders of pigmentation. She is listed in Best Doctors in America and is a diplomat of the American Board of Dermatology. McMichael has served on several editorial review boards and is a contributing editor for Cosmetic Dermatology as well as a contributing editor for reviews in The Dermatologist.
Andrew Ching is a professor in the Carey Business School at the Johns Hopkins University, where he is jointly appointed to the Department of Economics and the Bloomberg School of Public Health. He is currently serving as an Associate Editor for Management Science, and a member of editorial boards for Marketing Science and Journal of Marketing Research. His research focuses on developing new empirical structural models and estimation methods to understand the forward-looking, strategic, learning and bounded rational behavior of consumers and firms. He has applied these methods to several industries including prescription drugs, nursing homes, payment methods, retail banking, peer-to-peer lending, and video games. He has published in Econometrica, Mangement Science, Marketing Science, Journal of Banking and Finance, Journal of Applied Econometrics, and others. He has received Young Economist Award from the European Economic Association, Honorable Mention of Dick Wittink Prize Award, and several major research grants from Social Sciences and Humanities Research Council in Canada.
Climate Change, Social Policy, Human Rights, Gender, Poverty, urban social change, natural resource governance, social inclusion, social analysis
Dr. Andrew M. Evens is a physician-scientist at the Rutgers Cancer Institute of New Jersey, where he is Associate Director for Clinical Services and Director of the Lymphoma Program. In addition, he is the Medical Director of the Oncology Service Line for the RWJBarnabas Health system. Dr. Evens completed a Hematology/Oncology fellowship at Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, where he was also Director of Translational Therapeutics. Prior to his Rutgers Cancer Institute appointment, Dr. Evens served as Chief of the Division of Hematology/Oncology at Tufts Medical Center and as Director of the Tufts Cancer Center in Boston, MA. Dr. Evens is an associate editor for the British Journal of Haematology and serves on the editorial board for the Journal of Clinical Oncology. He is a core member of the Hodgkin Lymphoma Working Group for the NIH/NCI Steering Committee and has been a member of several clinical and scientific committees for the NIH, NCI, Cancer Therapy Evaluation Program (CTEP), Food and Drug Administration (FDA) and the ECOG/ACRIN group. Dr. Evens is also an elected member of the Scientific Advisory Board for the Lymphoma Research Foundation (LRF) and he is involved in multiple national and international educational forums and events. I completed a prior fellowship in hematology/oncology at Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center in Chicago, Illinois, where I also remained as a faculty member altogether for 10 years. Most recently, I served as the director of the Cancer Center at Tufts Medical Center in Boston, chief of their division of hematology/oncology, and Professor of Medicine at Tufts University School of Medicine. My clinical expertise and research interests are fully dedicated to the field of lymphoma (i.e., Hodgkin lymphoma and non-Hodgkin lymphoma). Over the past 15+ years, I have been the principal investigator of more than 80 national and international cancer clinical trials that have included phase I, II, and III studies, many which have been “investigator-initiated” trials studying new and novel targeted agents for the treatment of lymphoid malignancies. In addition to my clinical research, I also manage a translational laboratory studying the biology of lymphoma and to discover new and novel treatments for patients. Collectively, my research has been continuously funded by the National Institutes of Health (NIH) and the NCI since 2005. This has resulted in 200+ research abstracts at national and international cancer research symposiums, 150+ manuscripts in peer-reviewed publications, and 20+ book chapters all with an emphasis on the biology, prognosis, and treatment of lymphoma. My involvement in the advancement of cancer research has also included leadership roles in academic journals, symposiums, cancer advocacy groups, and international committees. I was an associate editor for the British Journal of Haematology and on the editorial board for the Journal of Clinical Oncology and am the inaugural editor in chief for the open access journal, eJHaem. I am a core member of the Hodgkin Lymphoma Working Group for the NIH/NCI Steering Committee and I have been a member of several additional clinical and scientific committees for the NIH, NCI, Cancer Therapy Evaluation Program (CTEP), Food and Drug Administration (FDA) and the ECOG/ACRIN group. Furthermore, I am Co-Chair of the Lymphoma Committee for the ECOG-ACRIN cancer research group and am honored to be an elected member of the North American Scientific Advisory Board for the Lymphoma Research Foundation (LRF) and a member of the Board of Trustees for the Leukemia & Lymphoma Society (LLS) New Jersey Chapter. Finally, I am involved and help lead a multitude of regional, national, and international educational forums and events. Positions: Associate Director for Clinical Services at Rutgers Cancer Institute of New Jersey Medical Director of the Oncology Service Line, RWJBarnabas Health Director, Lymphoma Program, Division of Blood Disorders Clinical Expertise: Hodgkin lymphoma, non-Hodgkin lymphoma (all types), chronic lymphocytic leukemia, and autologous hematopoietic stem cell (or bone marrow) transplantation. Research Interests: Lymphoma (Hodgkin lymphoma and non-Hodgkin lymphoma) Chronic lymphocytic leukemia and other lymphoid malignancies Clinical trials Translational studies, including lymphoma biology and drug discovery Systems biology and biomarker analyses Lymphoma epidemiology Health Outcomes, including Pharmacovigilance and Decision Making I am thrilled to be a member of the Rutgers Cancer Institute of New Jersey (CINJ) as the Associate Director for Clinical Services, Medical Director of the Oncology Service Line for RWJBarnabas Health, and Director of the Lymphoma Program. Rutgers Cancer Institute is unique in that it is New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center. Our mission is to deliver integrated cancer care across the health system with access to academic expertise and innovative cancer therapies not available elsewhere in the state.
Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the Phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involved active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology. Recently, she has published in Lancet Oncology the results of a Phase 1 clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials. Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients. Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the "Danny Danielson Translational Innovation Award" by Hoosier Cancer Research Network for her commitment to clinical research. She received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed a hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.
Ann Morning, author of The Nature of Race: How Scientists Think and Teach about Human Difference (University of California), is an associate professor of sociology at New York University. She is a member of the U.S. Census Bureau National Advisory Committee on Racial, Ethnic, and Other Populations and has served as a statistician for the bureau. Morning has also authored reports for the National Research Council’s Committee on the Use of Social Science Knowledge in Public Policy and the United Nations’ Statistics Division. Morning is also the academic director of 19 Washington Square North, NYU Abu Dhabi’s home in New York. Morning previously worked as an economist at the Federal Reserve Bank of New York and as a diplomat in the U.S. Foreign Service. From 1995 to 1997, she was an Assistant Dean for Academic Affairs at Columbia University’s School of International and Public Affairs. Morning received her B.A. magna cum laude from Yale, her Master’s in International Affairs from Columbia, and her Ph.D. in sociology from Princeton. She also studied at the Institut d’Etudes Politiques in Paris.
Professor of HistoryBinghamton University, State University of New York
African-American History, African Diaspora, History and Memory, African History, Civil Rights, Oral History, Race, Slavery, Immigration, Refugees, Human Rights
Bailey’s research interests include African-American history; African and African Diaspora studies; history and memory; oral history; and civil rights. She writes and speaks about a variety of topics related to these research areas, including race, slavery, immigration, refugees, diasporas, faith and history and human rights. In her work, Bailey combines the elements of travel, adventure, history and an understanding of contemporary issues with an accessible style. Her works range from adult non-fiction to children’s historical fiction, and includes African Voices of the Atlantic Slave Trade: Beyond the Silence and the Shame (Beacon Press, 2005) and You Can Make A Difference: The Story of Martin Luther King Jr. (Bantam/Doubleday/Dell). Her newest book, The Weeping Time: Memory and the Largest Slave Auction in American History, was published by Cambridge University Press in October 2017 and has received very wide coverage.
Knott's research examines the optimal environment and policies (economic, industrial and firm) for innovation, and is best summarized in her book, How Innovation Really Works (March 2017). This interest stems from issues arising during an earlier career in defense electronics at Hughes Aircraft Company.